|
Market Closed -
Bombay S.E.
11:24:22 17/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 89.83 INR | +6.66% |
|
+13.35% | +118.72% |
| 08-05 | Morepen Laboratories Limited announces Annual dividend, payable on October 26, 2026 | CI |
| 08-04 | Morepen Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 18.52B 194M 167M 157M 143M 269M 273M 1.84B 720M 9.27B 727M 711M 30.82B | P/E 2024 |
22.4x | P/E 2025 | 21.8x |
|---|---|---|---|---|---|
| Enterprise Value | 18.52B 194M 167M 157M 143M 269M 273M 1.84B 720M 9.27B 727M 711M 30.82B | EV / Sales 2024 |
1.27x | EV / Sales 2025 | 1.45x |
| Free-Float |
57.31% | Yield 2024 * |
-
| Yield 2025 | 0.42% |
| 1 day | +6.66% | ||
| 1 week | +13.35% | ||
| Current month | +57.60% | ||
| 1 month | +52.38% | ||
| 3 months | +117.35% | ||
| 6 months | +131.22% | ||
| Current year | +118.72% |
| 1 week | 73 |  | 90.41 |
| 1 month | 51.43 | | 90.41 |
| Current year | 33.44 | | 90.41 |
| 1 year | 33.44 | | 90.41 |
| 3 years | 31.31 | | 100.8 |
| 5 years | 23.65 | | 100.8 |
| 10 years | 7.21 | | 100.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sanjay Suri
CEO | Chief Executive Officer | 58 | 30/06/2026 |
Sushil Suri
CEO | Chief Executive Officer | 62 | 31/01/1992 |
| Director of Finance/CFO | 59 | 02/04/2002 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 31/01/1992 |
| Director/Board Member | 58 | 12/08/2019 | |
Savita
BRD | Director/Board Member | - | 21/06/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.66% | +13.35% | +87.50% | +141.28% | 483M | |
| -2.39% | -0.47% | +68.30% | +116.05% | 1,052B | |
| -0.66% | +0.43% | +47.39% | +51.02% | 627B | |
| -0.54% | +1.39% | +20.69% | +64.61% | 441B | |
| -0.04% | -4.93% | +38.55% | +37.51% | 349B | |
| +0.25% | -3.22% | +22.45% | +36.57% | 287B | |
| +0.85% | -3.59% | -1.52% | +7.12% | 241B | |
| -0.63% | +1.04% | +40.05% | +56.67% | 224B | |
| -0.82% | -4.49% | -15.86% | -54.13% | 202B | |
| +0.16% | +3.87% | +16.89% | +77.38% | 172B | |
| Average | +0.61% | -0.18% | +32.45% | +53.41% | 359.57B | |
| Weighted average by Cap. | +0.01% | -0.63% | +38.65% | +62.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 17.02B 178M 154M 144M 131M 247M 251M 1.69B 662M 8.52B 668M 654M 28.32B | 18.12B 189M 164M 154M 140M 263M 267M 1.8B 704M 9.07B 711M 696M 30.15B |
| Net income | 962M 10.06M 8.69M 8.16M 7.42M 13.96M 14.19M 95.63M 37.39M 482M 37.76M 36.94M 1.6B | 1.18B 12.34M 10.66M 10.02M 9.11M 17.13M 17.41M 117M 45.89M 591M 46.34M 45.33M 1.96B |
| Net Debt | 121M 1.26M 1.09M 1.02M 930K 1.75M 1.78M 11.99M 4.69M 60.36M 4.73M 4.63M 201M | -928K -9.7K -8.38K -7.88K -7.16K -13.47K -13.69K -92.29K -36.08K -465K -36.44K -35.65K -1.54M |
Employees
1,814
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/08/26 | ₹89.83 | +6.66% | 2,993,998 |
| 14/08/26 | ₹84.22 | +4.22% | 2,165,686 |
| 13/08/26 | ₹80.81 | +9.87% | 1,740,711 |
| 12/08/26 | ₹73.55 | -4.34% | 738,877 |
| 11/08/26 | ₹76.89 | -2.98% | 920,263 |
- Stock Market
- Stocks
- MOREPENLAB Stock
Select your edition
All financial news and data tailored to specific country editions
